NCT02317874 2023-08-29Testing the Addition of the Anti-Cancer Drug Talazoparib to the Combination of Carboplatin and Paclitaxel for the Treatment of Advanced CancerNational Cancer Institute (NCI)Phase 1 Completed43 enrolled